Professional Acne Medication Market by Top Manufactures, Industry Growth Analysis, Demand and Forecast 2030

The Professional Acne Medication Market size was valued at USD 2.80 billion in 2021 and is predicted to reach USD 5.45 billion by 2030 with a CAGR of 7.2% from 2022-2030.

Acne is one of the most common skin conditions caused due to dead skin cells, oil excreted from the skin, and clogged hair follicles. It is characterized by whiteheads, blackheads, pimples, and cysts. It affects millions of youngsters across the world. Also, body parts that are mostly affected by acne are face, shoulders, and upper part of the chest and back. Acne treatment is carried out largely by drying out the skin, making it a less inviting place for acne-causing and acne-promoting microbes to flourish. It is done either by medication or therapeutically.

Access Full Description of this report at:-

https://www.nextmsc.com/report/professional-acne-medication-market

Competitive Landscape

The market comprises of various players such as are Almirall SA., Bausch Health Companies Inc., Johnson & Johnson, GlaxoSmithKline Plc (GSK), Galderma S.A., Mayne Pharma Group Limited, Mylan N.V., Sun Pharmaceutical Industries Limited, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. These manufacturers are actively indulging in R&D initiatives, product & technology innovations, and industrial collaborations to enhance their product and increase their growth and geographical reach. For instance, in June 2021, Almirall S.A. has received United States Food and Drug Administration (FDA) approval to produce Seysara, a first-inclass tetracycline-derived oral antibiotic for the treatment of inflammatory lesions associated with the moderate to severe nonnodular acne vulgaris. Also, in April 2021, Teva Pharmaceutical Industries Ltd., launched strength generic version of Absorica capsules in 10-mg, 20-mg, 25-mg, 30-mg, 35-mg, and 40-mg dose. These capsules can be used for the treatment of severe recalcitrant nodular acne in non-pregnant patients of 12 years of age and above with multiple inflammatory nodules with a diameter of 5 mm or greater.

Market Segmentations and Scope of the Study:

The professional acne market has been segmented based on distribution channel, acne type, therapeutic class, formulation, and geography. Based on distribution channel, the market is bifurcated into med spa, aestheticians, dermatologist, and other professional channels. Based on acne type, the market is bifurcated into non-inflammatory acne and inflammatory acne. Based on therapeutic class, the market is divided into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others. The retinoids segment is further classified into topical retinoid & combination retinoid, and oral retinoid (isoretinion). The antibiotics segment is further classified into topical antibiotic & combination antibiotics, and oral antibiotics. Based on formulation, the market is divided into topical medications and oral medications. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and RoW.

Request sample copy of this report at:-

https://www.nextmsc.com/professional-acne-medication-market/request-sample

Geographical Analysis

North America region holds the lion share of professional acne medication market and is expected to continue dominating the market during the forecast period. This is attributed to factors such as surge in use of skin care products and rising prevalence of this condition in this region. Also, increasing awareness on new drugs as well as presence of many more drugs in the pipeline of pharma companies, such as Johnson & Johnson, Pfizer Inc., and Bausch Health Companies Inc. are expected to boost the demand for such products in the coming years.

Asia Pacific, on the other hand is expected to show a steady rise in the professional acne medication market due to high demand for acne therapeutics, and surge in healthcare expenditure as well as growth in awareness related to new developed therapeutics that can replace conventional acne treatment in this region. Furthermore, presence of major players such as The Derma Co., Skin Kraft, Soul Tree, and Plum Goodness boost the market growth in this region.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.